Home / Healthcare / eClinical Solutions Market

eClinical Solutions Market Size, Share & Industry Analysis, By Product Type (Clinical Trial Management Systems (CTMS), Electronic data capture (EDC) and Clinical data management systems (CDMS)), By Delivery Mode (Web-hosted, Licensed enterprise, Cloud-based), By Clinical Trial Phase (Phase I, Phase II, Phase III, Phase IV), By End User (Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, Contract Research Organizations) And Regional Forecast, 2024-2032

Report Format: PDF | Published Date: Ongoing | Report ID: FBI105464 | Status : Upcoming

eClinical solutions are applications and software that are used for management of clinical trials and clinical research. It manages the clinical technologies and expertise to facilitate the acceleration of clinical development process. These software helps in efficient and accurate research planning as well as in accurate reporting & documentation of clinical trials data. As per First analysis security corporation analysis, Clinical trial management systems (CTMS) and electronic data capture (EDC) are the most prominent eClinical solutions. With these solutions, sponsors and trial managers are competent to better manage the increased data volumes to execute on emerging trial. Additionally, market is also driven by growing customer base for eClinial solutions.


The rising trend of outsourcing clinical trials to contract research organizations (CROs) is poised to help the market grow. Outsourcing is an imperative means for clinical trial sponsors to bring in outside expertise, from full-service clinical research organizations to smaller functional service providers. As per IQVIA, globalization adds a new feature to clinical trial outsourcing, with more than 80% of manufacturers performing trials in more than one country, compared to less than half that a decade ago. In 2019 there were around 3,000 contract research organizations (CROs) operating universally with total combined market revenues exceeding USD 21 billion.


However, the high cost for implementation and maintenance of eclinical solutions is going to hamper the market growth. Additionally, increase in regulatory burdens exacerbated by increases in clinical trial complexity and data volumes, thus restraining the growth of eClinical Solutions market in the coming years.



Market Segmentation:


Globally, the eClinical Solutions market can be categorized into product type, delivery mode, clinical trial phases, end users and region. Based on Product type, the market can be segmented into clinical trial management systems (CTMS), electronic data capture (EDC) and clinical data management systems (CDMS), electronic clinical outcome assessment (eCOA), safety solutions, clinical analytics platform randomization and trial supply management (RTMS) and others. Based on delivery mode, the market can be categorized into web-hosted (On-demand), licensed enterprise (On-premise), cloud-based. On the basis of clinical trial phase, the market is segmented into phase I, phase II, phase III, phase IV. By end user, the market is segmented into pharmaceutical & biotechnology companies, hospitals & clinics, contract research organizations (CROs) and others. Geographically, the eClinical solutions market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.


Key Players Covered:


Some of the major companies that are present in the eClinical Solutions market are eClinical Solutions, Inc, Oracle Corporation (US), Medidata Solutions, Inc., PAREXEL International Corporation; CRF Health, Merge Healthcare (IBM), Datatrak Int, ALTEN Group and other prominent players.


Key Insights:



  • Key Industry Developments – Merger, Acquisitions, and Partnerships

  • Regulatory Scenario

  • Key Industry Trends

  • COVID-19 Impact on eClinical Solutions Market


Regional Analysis:


Based on region segmentation, the eClinical Solutions market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is estimated to dominate the market in 2020 and is estimated to retain its dominating position during the forecast period. Factors such as rising clinical research activities in U.S. and promptly shift from manual data interpretation to real-time data analysis during clinical studies will further accelerate the market revenue.  In Europe, the market is impelled by factors such as expansion of business and increase in customer base by the major players. For example, in January 2021, Bioclinica, an integrated solutions provider of clinical life science and technology expertise, had announced its partnership with IKCON PHARMA, which will allow sponsors to easily scale projects to restructure clinical trials. Asia Pacific is supplemented by rising number of trials that are outsourced to countries like China, India and Japan because of large patient population. The market in Latin America and Middle East countries, and Africa is expected to grow slower than other regions.



Segmentation






























 ATTRIBUTE


  DETAILS

By Product Type




  • Clinical Trial Management Systems (CTMS)

  • Electronic data capture (EDC) and Clinical data management systems (CDMS)

  • Electronic clinical outcome assessment (eCOA)

  • Safety solutions

  • Clinical analytics platform randomization and trial supply management (RTMS)

  • Others



By Delivery Mode




  • Web-hosted (On-demand) L

  • Licensed enterprise (On-premise)

  • Cloud-based.



By Clinical Trial Phase




  • Phase I

  • Phase II

  • Phase III

  • Phase IV



By End User




  • Pharmaceutical & Biotechnology Companies

  • Hospitals & Clinics, Contract Research Organizations (CROs)

  • Others



By Geography




  • North America (USA, Canada)

  • Europe (UK, Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)

  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacific)

  • Latin America (Brazil, Mexico, the Rest of Latin America)

  • Middle East & Africa (South Africa, GCC, and the Rest of the Middle East & Africa)



eClinical Solutions Market Industry Developments



  • In October 2020, Medidata, TriNetX, and Datavant announced a partnership which aims at accelerating the use of real-world data (RWD) to power clinical research. This partnership will allow users of Medidata’s end-to-end clinical research platform to securely link their clinical data with patient consent to de-identified patient data without unblinding the study

  • In November 2019, eClinicalWorks a leader in healthcare IT solutions came into collaboration with GuideWell; Humana Inc.; and Trusted Health Plan with an aim to provide bidirectional interoperability solutions to patients, providers, and payers.

  • Global
  • 2023
  • 2019-2022
  • PRICE
  • $ 4850
    $ 5850
    $ 6850
    Pre Book

Healthcare Clients